-
As the popularity of cryptocurrencies such as Bitcoin explode, the Biden administration is laying the groundwork for heavier regulation, and that could spark a big fight in Congress.
-
Tucker Carlson's new three-part series on the Jan. 6 siege of the U.S. Capitol relies on a rogue's gallery of conspiracy theorists to divert blame from supporters of former President Donald Trump.
-
Executives from the three social media giants testified before a Senate subcommittee Thursday about what they are doing to ensure the safety of their youngest users.
-
Tesla shares surged after Hertz announced a deal to buy Model 3s for rental at airports across the world. Analysts say it could boost sales of electric vehicles.
-
Amazon workers in New York plan to take an initial step toward forming a union. Organizers say they have collected some 2,000 signatures for a union vote from warehouse workers on Staten Island.
-
Moderna says a study in kids 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response.
-
NPR's Rachel Martin talks to the Washington Post's Tory Newmyer about new documents that show that CEO Mark Zuckerberg approved a decision to crack down on political dissenters in Vietnam.
-
Amazon warehouse staff in Staten Island are planning to file for a union vote. Some 2,000 workers have signed cards seeking an election, according to the self-organized independent Amazon Labor Union.
-
Leaked documents from inside Facebook show the social network was caught flat-footed by the "Stop the Steal" movement, which culminated in the Jan. 6 siege on the U.S. Capitol.
-
The Biden administration hopes to help fund its agenda by cracking down on tax evasion, but its plan to require more bank information is drawing strong opposition from GOP lawmakers and banks.
-
Traditionally, brands rarely mention their competitors, and if they do it's likely to attack them. But one study shows how brands praising their competitors might actually help boost their sales.
-
The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.